1960s external beam radiation major curative treatment options patients clinically localized prostate cancer efforts improve efficacy modality focused delivering higher dose recent randomized trials confirmed higher dose results improved oncological outcomes particularly patients disease technological advancements past NUMBER decades allowed highly conformal treatments spare normal tissue reduce early treatment effects complementary fashion methods developed better localization prostate radiation fields shifted treatment match daily shifts position target leading greater accuracy allowing smaller treatment margins turn overlap normal tissue newer expensive technologies radiation therapy protons used increasing frequency treatment prostate cancer imperative study risks benefits new modality informed decisions similarly growing hypofractionation means exploiting supposed low ratio prostate cancer shorten overall treatment time improve convenience lower costs new technology necessary proceed caution arena hypofractionation await results trials help determine risks benefits hypofractionation biological assumptions underlying ratio translate true clinical advantage references NUMBER intermediate risk long term real time intensity modulated cost benefit long term alpha beta alpha beta